A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
Clinical trial NCT00333008 · UNKNOWN
Trial details
- NCT number
- NCT00333008
- Sponsor
- The Alvin and Lois Lapidus Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.